Free STEP1 Exam Braindumps
Step1 Questions 377–381 (page: 77)

Updated On: 9-Feb-2026

Regulation of iron homeostasis occurs by controlling the amount that circulates in the serum, as well as the amount contained within cells. One mechanism that plays a role in this homeostasis is iron- mediated control of the level of the intracellular iron-binding protein ferritin. Which of the following represents the mechanism of iron regulation of ferritin levels?

  1. Binding of iron to ferritin leads to secretion of the complex from cells and subsequent excretion in the urine.
  2. Ferritin exists as a tetramer and when iron binds, the affitinity for additional iron atoms increases.
  3. Iron binds an additional protein that acts as a regulator of ferritin mRNA translation, high iron leads to increased translation and thus increased ironbinding capacity.
  4. When excess iron binds to ferritin, it decreases the half-life of the protein allowing the iron to be released to the plasma and excreted.

Answer(s): C

Explanation:

Ferritin is an iron-binding protein that prevents toxic levels of ionized iron (F ) from building up in
cells. As iron levels increase, the need to increase the amount of ferritin also increases. Iron-mediated regulation of ferritin levels occurs through the action of an iron response element-inding protein (IRBP) that binds to specific iron response elements (IREs) in the 5'-UTR of the ferritin mRNA. These IREs form hairpin loop structures that are recognized by IRBP. This IRBP is an iron-deficient form of aconitase, the iron-requiring enzyme of the TCA cycle. When iron levels are high, IRBP cannot bind to the IRE in the 5'- UTR of the ferritin mRNA. This allows the ferritin mRNA to be translated. When iron levels are low, IRBP is free of iron and can therefore, interact with the IRE in the ferritin mRNA preventing its translation. Binding of iron by ferritin does not increase its excretion in the urine (choice A). Ferritin does not exist as a multimeric protein exhibiting iron binding cooperativity (choice B). Iron binding to ferritin does not affect the halflife of ferritin (choice D).



Regulation of cholesterol, fatty acid, phospholipid, and triglyceride synthesis is controlled in part by the level of sterols. These sterol-regulated biosynthesis pathways involve a unique family of transcription factors that are best described by which of the following?

  1. Binding of sterols to these factors induces a conformational change preventing interaction with RNA polymerase.
  2. They are membrane-bound proteins and only released on activation of a sterolregulated protease.
  3. They contain zinc fingers that bind sterols leading to their activation.
  4. They require interaction with sterols, much like steroid hormone receptors, prior to binding to DNA.
  5. On sterol binding, these factors are recognized by the proteosome and thus targeted for degradation.

Answer(s): B

Explanation:

The continual alteration of the intracellular sterol content occurs through the regulation of key sterol synthetic enzymes, as well as by altering the levels of cell-surface LDL receptors. As cells need more sterol they will induce their synthesis and uptake, conversely when the need declines synthesis and uptake are decreased. Regulation of these events is brought about primarily by sterol-regulated transcription of key rate-limiting enzymes and by the regulated degradation of HMGR. Activation of transcriptional control occurs through the regulated cleavage of the membrane- bound transcription factor SREBP (there are three SREBPs). Sterol control of transcription affects more than 30 genes involved in the biosynthesis of cholesterol, triacylglycerols, phospholipids, and fatty acids. Transcriptional control requires the presence of an octamer sequence in the gene termed the sterol regulatory element, SRE-1. It has been shown that SREBP is the transcription factor that binds to SRE- 1 elements. All three SREBPs are proteolytically regulated by sterols. Full-length SREBPs have several domains and are embedded in the membrane of the ER. The N-terminal domain contains a transcription factor motif of the basic helix-loop-helix (bHLH) type that is exposed to the cytoplasmic side of the ER (see below figure). When sterols are scarce, cleavage of the full-length SREBP takes place with the result being that the N-terminal bHLH motif is released into the cytosol. The bHLH domain then migrates to the nucleus to direct transcription. Conversely, when sterols are abundant, cleavage of SREBP is inhibited. To control the level of SREBP-mediated transcription, the soluble bHLH domain is itself subject to rapid proteolysis. The cleavage of SREBP is carried out by two distinct enzymes, one of which is regulated by sterols. The regulated cleavage occurs in the lumenal loop between the two transmembrane domains. This cleavage is catalyzed by site-1 protease, S1P. High sterol content blocks the activity of S1P. The second cleavage, catalyzed by site-2 protease, S2P, occurs in the first transmembrane span, leading to release of active SREBP. In order for S2P to act on SREBP, site-1 must already have been cleaved. Additional studies on sterol-regulated gene expression demonstrated that cleavage of SREBP by S1P is controlled by the level and action of an additional protein termed, SREBP leavage-activating protein, SCAP.

SCAP is a large protein also found in the ER membrane and contains at least eight transmembrane spans.
The C-terminal portion, which extends into the cytosol, has been shown to interact with the C- terminal domain of SREBP. This C-terminal region of SCAP contains four motifs called WD40 repeats. The WD40 repeats are required for interaction of SCAP with SREBP. The function of SCAP is to positively stimulate S1P-mediated cleavage of SREBP. The function of sterols is to inhibit this positive action of SCAP. The activity of SCAP involves movement from the ER to the Golgi and back. Because the C-terminus of SCAP interacts with SREBP, movement of SCAP takes SREBP along for the ride. When sterols are low, SCAP and SREBP move to the Golgi. This transit is required for SREBP cleavage as S1P is Golgi-localized.
When sterols are high, movement of SCAP is halted. Thus, the overall effect of sterols is to regulate the ability of SCAP to present SREBP to S1P. None of the other choices (A, CE) represent the mechanisms of sterol-mediated regulation of gene expression.



Metformin is one of the most prescribed hypoglycemia-inducing drugs in the treatment of Type II diabetes. One of the effects of metformin is a reduction in adipose tissue lipolysis, which is effected via the activation of AMP-activated kinase (AMPK). Which of the following actions of AMPK explains the adipose tissue benefits of metformin?

  1. activation of ACC
  2. activation of FAS
  3. inhibition of hormone-sensitive lipase
  4. inhibition of mammalian target of rapamycin (mTOR)
  5. inhibition of 6-PFK-2

Answer(s): C

Explanation:

AMP-activated protein kinase (AMPK) was first discovered as an activity that inhibited preparations of ACC and 3-hydroxy-3-methylglutaryl- CoA reductase (HMG-CoA reductase, HMGR) and was induced by AMP.
AMPK induces a cascade of events within cells in response to the ever changing energy charge of the cell.
The role of AMPK in regulating cellular energy charge places this enzyme at a central control point in maintaining energy homeostasis (see below figure). Once activated, AMPK- ediated phosphorylation events switch cells from active ATP consumption (e.g., fatty acid and cholesterol biosynthesis) to active ATP production (e.g., fatty acid and glucose oxidation). Other important activities attributable to AMPK are regulation of insulin synthesis and secretion in pancreatic islet beta-cells. As shown in

AMPK inhibits (not activates) both ACC (choice A) and FAS (choice B). Activation (not inhibition) of PFK-2 (choice E) occurs in response to AMPK. Although AMPK does indeed inhibit mTOR (choice D), this inhibition does not have any influence on adipose tissue lipolysis.



The protein encoded by the APC gene is a tumor suppressor the role of which is to regulate the activity of cellular signaling induced by the Wnt growth factor. Therefore, loss of APC activity is associated with unrestrained cellular proliferation. Which of the following signaling molecules is the target for APC interaction?

  1. beta-catenin
  2. MYC
  3. p53
  4. pRB
  5. von Hippel-Lindau protein (pVHL)

Answer(s): A

Explanation:

The protein of the Wnt signaling cascade, to which APC associates, is beta-catenin. Using antibodies specific for the NH2-terminus of APC, it was possible to coprecipitate additional PCassociated proteins leading to the identification that one of these APC-associated proteins was beta-catenin. The catenins are a family of proteins that interact with the cytoplasmic portion of the cadherins (cell-cell adhesion family of proteins), thus linking the cadherins to the actin cytoskeleton. Catenins are equally important in the signaling cascade initiated by the Wnt family of proteins that are involved in embryonic patterning, development of the nervous system. The Wnt proteins are secreted factors that interact with cell-surface receptors. Wntreceptor interaction induces the activity of the cytoplasmic phosphoprotein dishevelled.
Activated dishevelled inhibits the serine/ threonine kinase glycogen synthase kinase-3- beta (GSK-3).
When GSK-3-beta is inhibited, beta-catenin becomes hypophosphorylated. The hypophosphorylated form of beta-catenin migrates to the nucleus and interacts with transcription factors, thereby, inducing expression of various genes. The role of APC in this pathway is to bind phosphorylated beta-catenin. The APC-beta-catenin complex stimulates the breakdown of beta-catenin. Therefore, mutations that lead to a loss of APC, or to a loss of the portion of the APC protein that interacts with beta-catenin, would lead to constitutive activation of several genes that could then promote the transformed phenotype. None of the other proteins (choices BE) are known to interact with APC.



A student has a genetic defect and cannot produce the J chain which is important in the structure of some immunoglobul in molecules. Which of the following will most likely be observed in this individual?

  1. a decrease in mature B cells
  2. a decrease in mature T lymphocytes
  3. a decrease in serum IgM
  4. an increase in IgA in the intestine
  5. an increase in serum IgM and decrease in IgE

Answer(s): C

Explanation:

Deficiency in production of J chains for immunoglobulins could result in a decrease in serum IgA and IgM levels. These antibodies are dimers and pentamers, respectively, of the basic immunoglobulin molecule, and require a J chain to join the immunoglobulin chains. There is no evidence which indicates that a deficiency in the production of J chains of IgA or IgM will cause a decrease in mature B cells, or T lymphocytes, an increase in serum IgM and decrease in IgE, or a decrease in IgA (choices A, B, D, and E).



Viewing page 77 of 171
Viewing questions 381 - 385 out of 845 questions


Post your Comments and Discuss USMLE STEP1 exam prep with other Community members:

AI Tutor AI Tutor 👋 I’m here to help!